Glenmark’s outlicensing deal with AbbVie for a novel drug for blood cancer under development sets a new course for the ...

But now, an Indian company has delivered a promising innovative anti-cancer drug molecule to deep-pocketed Big Pharma for ...

We are just trying to regroup. One wrong move takes you back by four or five years,' Glenn Saldanha said, emphasising caution ...

Chairman and Managing Director Glenn Saldanha said on Monday that the company has several assets under development, including ...

Motilal Oswal Financial Services recommends Suzlon and Glenmark Pharma as top stock picks for the week starting July 14, 2025. Suzlon anticipates healthy order inflows, potentially reaching 6.5GW by ...

In March, the company had received approval from the drug regulator to import and sell sodium zirconium cyclosilicate powder ...

A warning letter is a serious communication from the USFDA that signifies a potential risk to public health or safety due to ...